
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has shown a solid performance in recent quarters, buoyed by its strong presence in Asia and effective wealth management strategies. However, there are concerns regarding its valuation, as it is perceived to be somewhat overbought, trading over 2x book value with limited earnings growth expected in the near future. Despite these concerns, many experts highlight its decent dividend yield and ongoing growth potential, particularly in its Asian markets. The recent implementation of a tax on MFC products for mainland Chinese residents adds a layer of uncertainty. Overall, the sentiment among analysts is cautiously optimistic, with a call for careful monitoring of market conditions and potential entry points for investment.
Doesn’t see many of the Canadian insurers increasing dividends until they get more clarity on some of the regulatory rules with regard to capital. Cut their dividend in 2008 so probably won’t raise it again until they are very sure they are going to be able to maintain it. He is getting more positive on the Canadian insurance space; however the market has run these companies up in expectation of higher rates. It will have to be their core business that propels the next move in the stock. He would be cautious but thinks you should own some insurance in your portfolio. Prefers Sun Life (SLF-T), which has a better dividend yield and a little better stability.
Sell or hold for more upside? When you see a chart like this one has, there is always a temptation to become a trader. There is probably more upside in this stock. Has been crushed because of lower interest rates. His view is there will be higher interest rates and this is very well-positioned, especially in Asia.
Manulife (MFC-T) or Sun Life (SLF-T)? Low interest-rate environment that we had been in for the last 3-4 years has been terrible for insurance companies. We are now in an environment where everybody expects bond yields to go up, which can only be positive for life companies going forward and it is expected to see better earnings on their portfolios. Feels this one probably has more leverage as it has more international exposure and a little bit more scale.
(A Top Pick Dec 21/12. Up 50.16%.) Still sees value in this. Right now, the lifecos in particular, are in a cycle where, going forward, there is going to be more operating efficiencies. They are very cost conscious now. Also, expects there will be some operating leverages as the volume of business continues to expand. If interest rates start to rise, that is good for lifecos.
(A Top Pick Jan 21/13. Up 56.45%.) He would stay Long on insurance companies. This one is the insurance company that seems to be most exposed to a falling Cdn$. If you don’t own, consider buying on a little bit of a pull back.